John R. Horn, PharmD, FCCP and Philip D. Hansten, PharmD
1. Hafner V et al Effect of simultaneous induction and inhibition of CYP3A4 by St JohnÕs wort and ritonavir on CYP3A4 activity. Clin Pharmacol Ther. 2010;87:191-6.
2. Decloedt EH et al. Pharmacokinetics of lopinavir in HIV-infected adults receiving rifampin with adjusted doses of lopinavir-ritonavir tablets. Antimicrob Agents Chemother. 2011;55:3195-200.
3. Duval X et al. Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir. Antimicrob Agents Chemother. 2000;44:2593.
4. Song I et al. Effects of Etravirine alone and with ritonavir-boosted protease inhibitors on the pharmacokinetics of dolutegravir. Antimicrob Agents Chemother. 2011;55:3517-21.